# rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A

> **NCT03951103** · — · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 44 (actual)

## Conditions studied

- Hemophilia A With Inhibitor

## Interventions

- **OTHER:** rFVIIIFc

## Key facts

- **NCT ID:** NCT03951103
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-07
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03951103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03951103, "rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03951103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*